Drug or treatment

Ravulizumab clinical trials

• 14Clinical trials
• 18Countries

Newest trials

All recruiting trials (14)

• Ravulizumab for Generalized Myasthenia Gravis in Chinese Adults

  This trial tests ravulizumab in Chinese adults with generalized myasthenia gravis to see if it helps symptoms while checking safety and how the drug behaves in the body.

  Recruiting at 8 sites Phase 3 Alexion Pharmaceuticals, Inc. · Beijing and 9 other locations · NCT07596784

• Ravulizumab in Chinese adults with NMOSD

  This study tests ravulizumab in Chinese adults with NMOSD who are AQP4 antibody positive to see if it helps reduce relapses and is safe.

  Recruiting Phase 3 Alexion Pharmaceuticals, Inc. · Beijing and 9 other locations · NCT07557420

• Early ravulizumab for adults with myasthenic crisis in the ICU

  This project will test whether giving ravulizumab early to adults with AChR-positive generalized myasthenia gravis who are in the ICU for a myasthenic crisis helps speed recovery.

  Recruiting at 5 sites Centre Hospitalier Universitaire de Nice · Nice, Alpes-maritimes and 7 other locations · NCT07411963

• Ravulizumab Outcomes in Polish Patients with aHUS

  This observational study in Poland follows patients with atypical hemolytic uremic syndrome who are treated with ravulizumab to see how they do over time in real-world clinical care.

  Recruiting at 5 sites AstraZeneca · Gdansk and 9 other locations · NCT07399730

• Ravulizumab for people with clinical aHUS

  This study will test whether ravulizumab raises platelet counts in people diagnosed with clinical atypical hemolytic uremic syndrome (aHUS), including those with certain infections (excluding pneumococcal and STEC), pregnancy/postpartum, recent kidney transplant, malignant hypertension, or autoimmune conditions.

  Recruiting at 3 sites Phase 4 Alexion Pharmaceuticals, Inc. · Bunkyō City and 11 other locations · NCT07308574

• Oral steroid tapering for adults with generalized myasthenia gravis on ravulizumab.

  This study will try a predefined prednisone taper to see if adults with generalized myasthenia gravis on ravulizumab can safely reduce their daily steroid dose.

  Recruiting Phase 4 Alexion Pharmaceuticals, Inc. · Chicago, Illinois and 11 other locations · NCT07221838

• Ravulizumab for children with IgA nephropathy or IgA vasculitis nephritis

  This trial will test whether intravenous ravulizumab is safe and changes disease markers in children aged 2 to under 18 with biopsy‑proven IgA nephropathy or IgA vasculitis nephritis.

  Recruiting at 13 sites Phase 3 Alexion Pharmaceuticals, Inc. · Palo Alto, California and 14 other locations · NCT07024563

• Rituximab vs multiple approved NMOSD therapies to prevent relapses

  This study tests whether rituximab or one of four other approved medicines is better at preventing NMOSD relapses in adults who have AQP4-IgG.

  Recruiting at 2 sites Phase 4 Massachusetts General Hospital · Boston, Massachusetts and 2 other locations · NCT07010302

• Early ravulizumab for anti‑AChR antibody–positive generalized myasthenia gravis

  This study tests whether starting ravulizumab early can improve daily muscle weakness and function for people with anti‑AChR antibody–positive generalized myasthenia gravis.

  Recruiting at 9 sites Alexion Pharmaceuticals, Inc. · Bergamo and 22 other locations · NCT06967480

• Observational study on ravulizumab for generalized myasthenia gravis

  This study is looking at how well ravulizumab works for people with generalized myasthenia gravis over three years to see how it helps their health.

  Recruiting at 10 sites AstraZeneca · Bydgoszcz and 10 other locations · NCT06909253

• Evaluating Ravulizumab for Reducing Delayed Graft Function After Kidney Transplant

  This study is testing if a new drug called ravulizumab can help kidney transplant patients avoid delayed graft function and reduce the need for dialysis.

  Recruiting at 113 sites Phase 3 Alexion Pharmaceuticals, Inc. · Phoenix, Arizona and 129 other locations · NCT06830798

• Evaluating Danicopan with Ravulizumab or Eculizumab for Pediatric PNH Patients

  This study is testing if adding danicopan to the current treatments of ravulizumab or eculizumab can help kids with PNH have better hemoglobin levels.

  Recruiting at 4 sites Phase 3 Alexion Pharmaceuticals, Inc. · Saskatoon, Saskatchewan and 3 other locations · NCT06449001

• Evaluating the effects of ravulizumab in patients with neuromyelitis optica spectrum disorder

  This study is testing if the medication ravulizumab can help people with neuromyelitis optica spectrum disorder feel better and improve their MRI results.

  Recruiting University of Texas Southwestern Medical Center · Dallas, Texas · NCT06398158

• Using ravulizumab to treat severe preeclampsia in pregnant women

  This study is testing if the medication ravulizumab can help pregnant women with severe preeclampsia and HELLP syndrome feel better and stay safe.

  Recruiting Phase 2 Mayo Clinic · Rochester, Minnesota · NCT06333652

Quick answers

How many clinical trials of Ravulizumab are recruiting right now?

14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 18 countries. The most sites are in United States (6 trials), Japan (4 trials), Italy (4 trials), China (4 trials), France (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 5, Phase 4: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →